Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials

[31] Ren D(2014)Clinical observation of Tripterygium wilfordii polyglycoside on proteinuria in diabetic nephropathy Lishizhen Medicine Materia Medica Research 25 1676-7

[32] Zuo C(2009)Clinical observation of Tripterygium wilfordii on diabetic nephropathy Journal of Clinical Experimental Medicine 8 134-76

[33] Xu G(2013)The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients Chin J Intern Med 52 469-7

[34] Cai X-P(2020)Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR J Formos Med Assoc 119 685-7

[35] Wang W(2015)Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease Biotechnol Biotechnol Equip 29 139-92

[36] Nie C-Y(2012)A randomized controlled study of Tripterygium wilfordii polyglycoside in the treatment of diabetic nephropathy Hainan Medical Journal 23 31-9

[37] Chen L-M(2004)Serum albumin: relationship to inflammation and nutrition Semin Dial 17 432-26

[38] Chang B-C(2005)Diabetic nephropathy: diagnosis, prevention, and treatment Diabetes Care 28 164-undefined

[39] Chen H(2016)Diabetic nephropathy in women with preexisting diabetes: from pregnancy planning to breastfeeding Curr Diab Rep 16 12-undefined

[40] Zhuang L-P(2016)Clinical efficacy and safety of Tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis Open Med (Wars) 11 611-undefined

[31] Ren D(2014)Clinical observation of Tripterygium wilfordii polyglycoside on proteinuria in diabetic nephropathy Lishizhen Medicine Materia Medica Research 25 1676-7

[32] Zuo C(2009)Clinical observation of Tripterygium wilfordii on diabetic nephropathy Journal of Clinical Experimental Medicine 8 134-76

[33] Xu G(2013)The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients Chin J Intern Med 52 469-7

[34] Cai X-P(2020)Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR J Formos Med Assoc 119 685-7

[35] Wang W(2015)Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease Biotechnol Biotechnol Equip 29 139-92

[36] Nie C-Y(2012)A randomized controlled study of Tripterygium wilfordii polyglycoside in the treatment of diabetic nephropathy Hainan Medical Journal 23 31-9

[37] Chen L-M(2004)Serum albumin: relationship to inflammation and nutrition Semin Dial 17 432-26

[38] Chang B-C(2005)Diabetic nephropathy: diagnosis, prevention, and treatment Diabetes Care 28 164-undefined

[39] Chen H(2016)Diabetic nephropathy in women with preexisting diabetes: from pregnancy planning to breastfeeding Curr Diab Rep 16 12-undefined

[40] Zhuang L-P(2016)Clinical efficacy and safety of Tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis Open Med (Wars) 11 611-undefined